NVO Competitors & Alternatives

Compare Novo Nordisk A/S with similar stocks in the same industry

Drug Manufacturers - General

NVO

Main Stock
$39.05
Tradestie Score
51
Market Cap
$262.92B
P/E Ratio
9.6
Revenue Growth
0.0%
Analyst Upside
+15.6%

Top Competitors

20 stocks in Drug Manufacturers - General
Company Price Market Cap P/E Score Action
AZN AstraZeneca PLC
$171.49
$261.56B 25.2 46 Compare
NVS Novartis AG
$151.12
$254.99B 23.3 31 Compare
MRK Merck & Co., Inc.
$145.27
$225.13B 119.0 56 Compare
AMGN Amgen Inc
$439.26
$160.70B 27.2 27 Compare
PFE Pfizer Inc.
$30.03
$154.70B 39.3 32 Compare
GILD Gilead Sciences Inc
$156.04
$137.92B - 41 Compare
SNY Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
$41.60
$121.27B 21.6 51 Compare
BMY Bristol-Myers Squibb Co.
$61.48
$96.54B 13.5 61 Compare
GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares)
$50.75
$91.59B 15.8 35 Compare
SMCI Super Micro Computer, Inc. Common Stock
$32.94
$31.13B 10.9 59 Compare

Data updated: Oct 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)

20 stocks in this industry